Treats lead poisoning. Sold as Chemet. Every FDA application for this active ingredient.
As of Nov 13, 2026, FDA lists 1 application for Succimer (sold as Chemet), first approved Jan 30, 1991, with 0 new uses approved and 0 published complete response letters.
| Product | Part | Spending, 2024 | Change | Beneficiaries |
|---|---|---|---|---|
| Chemet | Part D | $92K | -40% | 27 |
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Jan 30, 1991 | ChemetNDA 19998 ยท New molecular entity | Recordati Rare | 16 | Marketed |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number. Drugs@FDA
